WO1999020587A1 - Procede d'extraction et de purification de la luteine, de la zeaxanthine et de carotenoides rares dans les fleurs et plantes de tagete - Google Patents
Procede d'extraction et de purification de la luteine, de la zeaxanthine et de carotenoides rares dans les fleurs et plantes de tagete Download PDFInfo
- Publication number
- WO1999020587A1 WO1999020587A1 PCT/US1998/022229 US9822229W WO9920587A1 WO 1999020587 A1 WO1999020587 A1 WO 1999020587A1 US 9822229 W US9822229 W US 9822229W WO 9920587 A1 WO9920587 A1 WO 9920587A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lutein
- zeaxanthin
- extraction
- mixture
- alcohol
- Prior art date
Links
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 161
- 239000001656 lutein Substances 0.000 title claims abstract description 100
- 229960005375 lutein Drugs 0.000 title claims abstract description 100
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 97
- 235000012680 lutein Nutrition 0.000 title claims abstract description 97
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 97
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 97
- 235000021466 carotenoid Nutrition 0.000 title claims abstract description 80
- 150000001747 carotenoids Chemical class 0.000 title claims abstract description 78
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 67
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 title claims abstract description 63
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 title claims abstract description 63
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 title claims abstract description 63
- 235000010930 zeaxanthin Nutrition 0.000 title claims abstract description 63
- 239000001775 zeaxanthin Substances 0.000 title claims abstract description 63
- 229940043269 zeaxanthin Drugs 0.000 title claims abstract description 63
- 235000005881 Calendula officinalis Nutrition 0.000 title claims abstract description 30
- 241000196324 Embryophyta Species 0.000 title claims abstract description 25
- 238000000605 extraction Methods 0.000 title claims description 43
- 230000008569 process Effects 0.000 title abstract description 30
- 240000000785 Tagetes erecta Species 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title description 19
- 239000000203 mixture Substances 0.000 claims abstract description 50
- 241000736851 Tagetes Species 0.000 claims abstract description 39
- 239000013078 crystal Substances 0.000 claims abstract description 22
- 235000021028 berry Nutrition 0.000 claims abstract description 21
- 244000241872 Lycium chinense Species 0.000 claims abstract description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 94
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 78
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 27
- 238000007127 saponification reaction Methods 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 19
- 230000007062 hydrolysis Effects 0.000 claims description 16
- 238000006460 hydrolysis reaction Methods 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 12
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 12
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 229930002875 chlorophyll Natural products 0.000 claims description 8
- 235000019804 chlorophyll Nutrition 0.000 claims description 8
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 claims description 8
- 229940107604 lutein esters Drugs 0.000 claims description 8
- 150000002658 luteins Chemical class 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 7
- 229910002027 silica gel Inorganic materials 0.000 claims description 7
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 5
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000003749 zeaxanthins Chemical class 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 4
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 claims 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 abstract description 23
- 241000282414 Homo sapiens Species 0.000 abstract description 14
- 235000013305 food Nutrition 0.000 abstract description 14
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 abstract description 13
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract description 12
- 235000013734 beta-carotene Nutrition 0.000 abstract description 12
- 239000011648 beta-carotene Substances 0.000 abstract description 12
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract description 12
- 239000011774 beta-cryptoxanthin Substances 0.000 abstract description 12
- 229960002747 betacarotene Drugs 0.000 abstract description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract description 12
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 abstract description 11
- NBZANZVJRKXVBH-DJPRRHJBSA-N (3R,6'R)-beta,epsilon-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=CCCC1(C)C NBZANZVJRKXVBH-DJPRRHJBSA-N 0.000 abstract description 11
- 235000012308 Tagetes Nutrition 0.000 abstract description 11
- NBZANZVJRKXVBH-GYDPHNCVSA-N alpha-Cryptoxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@H]2C(C)=CCCC2(C)C)\C)/C)\C)/C)=C(C)C1 NBZANZVJRKXVBH-GYDPHNCVSA-N 0.000 abstract description 11
- 235000005861 alpha-cryptoxanthin Nutrition 0.000 abstract description 11
- 235000002360 beta-cryptoxanthin Nutrition 0.000 abstract description 11
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 abstract description 11
- 241001464837 Viridiplantae Species 0.000 abstract description 9
- 240000007124 Brassica oleracea Species 0.000 abstract description 8
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 abstract description 8
- DYUUPIKEWLHQGQ-KYHIUUMWSA-N (3S, 5R, 6S, 3'R, 6'R)-5,6-epoxy-5,6-dihydro- beta,epsilon-carotene-3,3'-diol Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C DYUUPIKEWLHQGQ-KYHIUUMWSA-N 0.000 abstract description 5
- 244000064816 Brassica oleracea var. acephala Species 0.000 abstract description 5
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 abstract description 5
- PVNVIBOWBAPFOE-UHFFFAOYSA-N Dinoxanthin Natural products CC1(O)CC(OC(=O)C)CC(C)(C)C1=C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1(C(CC(O)C2)(C)C)C2(C)O1 PVNVIBOWBAPFOE-UHFFFAOYSA-N 0.000 abstract description 5
- DYUUPIKEWLHQGQ-UWYDEOQVSA-N Lutein 5,6-epoxide Natural products O[C@H]1C=C(C)[C@H](/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)\C)/C)\C)/C)C(C)(C)C1 DYUUPIKEWLHQGQ-UWYDEOQVSA-N 0.000 abstract description 5
- 235000009337 Spinacia oleracea Nutrition 0.000 abstract description 5
- 239000004213 Violaxanthin Substances 0.000 abstract description 5
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 abstract description 5
- PGYAYSRVSAJXTE-CLONMANBSA-N all-trans-neoxanthin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C=C=C1C(C)(C)C[C@H](O)C[C@@]1(C)O PGYAYSRVSAJXTE-CLONMANBSA-N 0.000 abstract description 5
- DYUUPIKEWLHQGQ-FJOIUHRLSA-N lutein 5,6-epoxide Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-FJOIUHRLSA-N 0.000 abstract description 5
- OWAAYLVMANNJOG-OAKWGMHJSA-N neoxanthin Natural products CC(=C/C=C(C)/C=C/C=C(C)/C=C=C1C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC23OC2(C)CC(O)CC3(C)C OWAAYLVMANNJOG-OAKWGMHJSA-N 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 235000019245 violaxanthin Nutrition 0.000 abstract description 5
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 2
- 244000300264 Spinacia oleracea Species 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 15
- 235000005911 diet Nutrition 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- -1 lauric Chemical class 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 230000000378 dietary effect Effects 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000012055 fruits and vegetables Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000008601 oleoresin Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 241000219315 Spinacia Species 0.000 description 5
- 206010064930 age-related macular degeneration Diseases 0.000 description 5
- 208000002780 macular degeneration Diseases 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- BMQNSHDVIYZULR-WZLJTJAWSA-N anhydrolutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C=CCC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C BMQNSHDVIYZULR-WZLJTJAWSA-N 0.000 description 4
- 238000010936 aqueous wash Methods 0.000 description 4
- 235000005471 carotenols Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000006317 isomerization reaction Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 229940083608 sodium hydroxide Drugs 0.000 description 4
- BMQNSHDVIYZULR-FKKUPVFPSA-N (1r)-3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol Chemical compound CC=1C=CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C BMQNSHDVIYZULR-FKKUPVFPSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 150000001748 carotenols Chemical class 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000000576 food coloring agent Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013557 residual solvent Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 231100000003 human carcinogen Toxicity 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- AOHAPDDBNAPPIN-UHFFFAOYSA-N myristicinic acid Natural products COC1=CC(C(O)=O)=CC2=C1OCO2 AOHAPDDBNAPPIN-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 238000000252 photodiode array detection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 2
- 229940044613 1-propanol Drugs 0.000 description 1
- 241000017163 Acephala Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229940025508 lutein / zeaxanthin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000804 nongenotoxic Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002943 palmitic acids Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000721 toxic potential Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0096—Purification; Precipitation; Filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/095—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of esters of organic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Definitions
- Carotenoids are amongst the most widespread of the naturally occurring groups of pigments and are found in all families of the plant and animal kingdoms. To date, as many as seven hundred carotenoids have been isolated from various sources and their chemical structures have been characterized. Numerous epidemiological studies in various populations have shown that consumption of substantial amounts of fruits and vegetables rich in carotenoids reduces the risk of acquiring several types of cancers. As a result, for nearly two decades, scientists have been focussing most of their attention on investigating the protective effect of beta-carotene in prevention of cancer, cardiovascular and eye diseases. This is despite the fact that beta-carotene is only one of the prominent carotenoids found in fruits and vegetables whose consumption has been associated with health benefits in humans. The reasons for such an intense focus can be attributed to the pro- vitamin A activity of beta-carotene and the lack of commercial availability of other prominent food carotenoids.
- lutein and zeaxanthin may be obtained from certain fruits and vegetables, the isolation of lutein from extracts of marigold flowers and zeaxanthin from berries ⁇ Lycium Chinese Mill (LCM berries) proves to be most economical.
- Marigold flowers lutein is the major carotenoid and is normally accompanied by about 3-6% zeaxanthin; in LCM berries zeaxanthin is the major carotenoid and is completely free from lutein.
- lutein and zeaxanthin are esterified with fatty acids such as lauric, myristic, and palmitic acids.
- the purification of lutein fatty acid esters from marigold flowers was patented by Philip in 1977 (U.S. Patent No.
- Marigold oleoresin is prepared by extraction of dried marigold petals in boiling n-hexane for extended periods of time. Since lutein/zeaxanthin, and carotenoids in general, are sensitive to heat treatment, this procedure can result in degradation or isomerization of these compounds. Furthermore, according to the Food and Drug administration's (FDA) Federal Register Documents, Code of Federal Regulations & Food, Drug, and Cosmetic act, n-hexane is considered among the solvents whose levels in foods and pharmaceutical products should be limited. The classification of organic solvents by the FDA will be described later in this text.
- the hydrolysis of lutein and zeaxanthin esters in the marigold oleoresin is conducted in an aqueous solution in the presence of alcohol and propylene glycol in which the fatty acid esters of lutein and zeaxanthin have very low solubility.
- this process requires high temperatures of up to 70°C and 10 hours to complete the saponification. This can once again result in the degradation and isomerization of lutein and zeaxanthin.
- the saponified product Due to the high viscosity of propylene glycol, during handling and several purification steps, the saponified product is additionally subjected to high temperatures ranging from 70 to 85°C. This un-necessary exposure to heat in the presence of air can result in oxidative degradation of lutein and zeaxanthin and formation of a number of side products.
- the process described here provides a convenient and economical route to lutein, zeaxanthin, and several minor carotenoids by employing a simultaneous extraction and saponification procedure at room temperature for only a few hours. Most importantly, this process addresses all the disadvantages and concerns with regard to all of the previously patented procedures described above. As a result, the lutein (from Marigolds) and zeaxanthin (from LCM berries) obtained by this process are in purity of 97% or greater and are therefore suitable for human consumption. This extraction and purification process has also been successfully employed for isolation of lutein and several minor carotenoids from green plants which serve as an alternative source for commercial production of lutein. BRIEF SUMMARY OF THE INVENTION
- This invention employs a simultaneous extraction and hydrolysis (saponification) procedure for isolation and purification of lutein, zeaxanthin, and several rare carotenoids from Marigold flowers, LCM berries, and green plants.
- the plants are mixed with tetrahydrofuran (THF) and sufficient amounts of ethanol or methanol (preferably food grade ethanol) with the addition of either 5% or 10% potassium or sodium hydroxide to maintain the pH at 12 and the mixture is homogenized at room temperature for 1 to 2 hours.
- THF tetrahydrofuran
- ethanol or methanol preferably food grade ethanol
- This process not only extracts carotenoids from plants under mild conditions, within a few hours, but it simultaneously hydrolyses the fatty acid esters of major dihydroxycarotenoids such as lutein and zeaxanthin as well as monohydroxycarotenoids such as alpha- cryptoxanthin and beta-cryptoxanthin which are present in minute quantities. As a result, the free and un-esterified forms of these hydroxycarotenoids are regenerated. In the case of green plants, in which lutein is present in its free form, the simultaneous extraction and saponification results in the conversion of chlorophylls to their water soluble derivatives and allows the removal of these compounds from lutein, beta-carotene, and other carotenoids.
- This treatment removes the salts of fatty acid esters, the base (potassium or sodium hydroxide), and the water soluble plant components.
- the resulting crystals of lutein or zeaxanthin are approximately 70% pure and contain minor quantities of other carotenoids.
- lutein or zeaxanthin are dissolved in minimum amount of THF, and water is added until the solution becomes cloudy; at this point the recrystalliztion of these compounds takes place.
- the mixture is then centrifuged and the solid crystals are washed with water or alcohol to remove the THF. After drying under high vacuum, the crystalline lutein or zeaxanthin are obtained in purities of 97% or greater.
- 70% lutein or zeaxanthin may be purified by passing a solution of these compounds in THF and water through a column packed with n- silica gel. After collection of the fraction containing lutein or zeaxanthin (greater than 97% purity), the THF is evaporated and the residue is washed with water or alcohol and dried as described above.
- alpha-cryptoxanthin and beta-cryptoxanthin Rosigolds and LCM berries
- lutein epoxide from greens
- all-E and Z isomers of carotenoids refer to all-trans and cis isomers of these compounds.
- all-trans and cis which have been used with the old nomenclature, are no longer appropriate.
- lutein or zeaxanthin refer to the most common geometrical forms (all-E or all-trans) of these carotenoids in plants.
- lutein esters or "zeaxanthin esters” refers to either mono- or di- esters without limitation.
- the present invention applies a simultaneous extraction and saponification process to three generally different plants sources for isolation of lutein and zeaxanthin; these are: dried petals of Marigolds (Tagete erecta), LCM berries (Lycium Chinese Mill), and several green vegetables such as Kale (Brassica oleracia, var. acephala), Spinach (Spinacia oleracia), and Collard green (Brassica oleracia, var. Champion). These plant sources of carotenoids are described as follows.
- Marigold flowers The dried petals of marigold flowers, are harvested and prepared in Central America and are imported into the U.S. Flowers are hand-picked and ensiled to preserve them until they can be economically dried.
- the marigold blossoms are then placed in a freeze drying apparatus and are dehydrated under controlled conditions. After dehydration, the flowers are put through a series of air separators and mechanical separators where the petals are separated from any other materials and converted to a homogenous Marigold meal.
- the carotenoids in Marigold meal are esterified with fatty acids such as lauric, myristic, and palmitic acid, however, upon hydrolysis the parent hydroxycarotenoids are regenerated.
- the major hydroxycarotenoid in Marigold is lutein which is normally accompanied by 3-6% of its isomeric compound, zeaxanthin.
- LCM berries are normally grown in China and can be obtained from most of the Chinese supermarkets across the U.S. However, a variety of this fruit is also currently grown on a commercial scale by Rehnborg Center for Nutrition in Lakeview, California.
- the author isolated several grams of zeaxanthin from LCM berries for a human supplementation study and demonstrated that this plant is an excellent source of zeaxanthin (Khachik et al., J. Cellular Biochem. 1995, 22:236-246).
- Zeaxanthin in LCM berries is mostly esterified with palmitic acid and only trace amounts of this compound is esterified with lauric and myristic acids.
- LCM berries do not contain any measurable amount of lutein but several other carotenoids such as alpha-cryptoxanthin, beta- cryptoxanthin, and beta-carotene are present in this fruit in minute quantities.
- carotenoids such as alpha-cryptoxanthin, beta- cryptoxanthin, and beta-carotene are present in this fruit in minute quantities.
- large quantities of the berries were purchased from a local Chinese supermarket.
- the draft guideline recommends acceptable amounts of residual solvents in pharmaceuticals for the safety of the patient as well as recommending the use of less toxic solvents in the manufacture of drug substances and dosage forms.
- solvents are divided into three classes. These are:
- Class 1 Solvents to be avoided. Known human carcinogens, strongly suspected human carcinogens, and environmental hazards.
- Class 2 Solvents to be limited. Nongenotoxic animal carcinogens or possible causative agents of other irreversible toxicity such as neurotoxicity or teratogenicity; solvents suspected of other significant but reversible toxi cities.
- Class 3 Solvents with low toxic potential to man. No health based exposure limit is needed. Class 3 solvents have Permitted Daily Exposure (PDE) of 50 milligrams (mg) or more per day.
- PDE Permitted Daily Exposure
- Ethanol and THF employed by the present invention are listed by the FDA in Class 3 and are therefore quite safe for commercial production of carotenoids for human use.
- the advantage of THF in compare to other organic solvents of Class 3 is due to the strong solubility of carotenoids in this solvent which allows the extraction of these pigments from the matrices of various plants in an efficient and speedy manner.
- THF is water soluble and therefore can be used in a homogenous phase extraction of carotenoids from plants in which significant amount of water may be present (Kale, Spinach, Collard green).
- the solubility strength of THF for carotenoids and the homogeneity of THF, ethanol, and water allow for the simultaneous extraction and saponification of carotenoids from plants.
- Marigold meal 100 g
- tetrahydrofuran 1000 ml
- sodium- or potassium hydroxide 25 g
- food grade ethanol 250 ml
- Preferred solvents are also selected for their boiling points. Solvents with boiling points of about 75°C to 120°C are preferred. Ethanol, with a
- the pH of the mixture is monitored and automatically maintained at about pH 12.
- An additional amount of sodium- or potassium hydroxide (25 g) in 250 ml of ethanol is normally needed to maintain the pH at 12.
- the extraction and saponification is completed in about 2 hours.
- the solvents are then evaporated and the residue is washed with 1000 ml of a 1/1 mixture water and alcohol to remove the base and the water soluble components.
- the lutein crystals are collected by centrifugation, washed with alcohol (100 ml), and dried under high vacuum overnight at room temperature.
- the lutein crystals (2.0 g) obtained are about 70% pure and can be recrystallized from a mixture of THF (20 ml) and water (30 ml) and dried under high vacuum overnight to give 1.2 g of lutein containing about 5% zeaxanthin in 97% purity.
- the above 70% pure lutein can also be purified by passing a solution of this compound in THF/water (1.5/1.0) through a column of n-silica gel and subsequent of washing of the column with this solvent mixture. After collection of the lutein fraction, the THF is evaporated, the crystals of pure lutein are collected by centrifugation, and washed with 20 ml of an alcohol, preferably ethanol, to remove the residual water from the product. Drying under high vacuum gives 1.2 g of 97% pure lutein containing about 5% zeaxanthin. In another fraction from this purification, about 0.3 g of a mixture of lutein, anhydrolutein, alpha- cryptoxanthin, and beta-cryptoxanthin is also obtained.
- Marigold meal 100 g was vigorously homogenized in a blender with tetrahydrofuran (THF, 1000 ml) and 10% ethanolic KOH (250 ml) at room temperature.
- the pH of the solution was kept at 12 by monitoring the extraction and hydrolysis with an automatic pH-meter.
- an additional 250 ml of 10% ethanolic KOH was needed to maintain the pH at 12. It is essential to avoid the addition of excessive amounts of the base to the mixture during the extraction and hydrolysis. This is because at a later purification step, the removal of the excess base will then require additional and un-necessary washing of the residue with large volumes of water which can be time consuming.
- the lutein crystals (2.0 g, 70% pure) were dissolved in THF (20 ml) and water (30 ml) was added to commence recrystallization. The mixture was stirred at room temperature for 10 minutes and the solids were separated by centrifugation. After removal of the solution, the lutein crystals were washed with ethanol (20 ml), centrifuged, and dried under high vacuum overnight at room temperature. This gave 1.2 g of lutein which was shown by HPLC-UV/Visible photodiode array detection coupled with Mass Spectrometry (MS) to be 97% pure but contained about 4% of all-E-zeaxanthin (Khachik et al. J. Chrom. Biomed. Appl. 582: 153-166, 1992).
- MS Mass Spectrometry
- the 70% pure lutein (2.0 g) was dissolved in THF (20 ml) and was passed through a glass column of n-Silica gel (15 cm L X 4 cm I.D.) packed under slight air pressure using THF/water (1.5/1.0). The column was washed with 200 ml of THF/water (1.5/1.0) and fractions 1 (50 ml) and 2 (150 ml) were collected. After evaporation of THF under reduced pressure at 40°C, and removal of water by centrifugation, fractions 1 and 2 were washed with 4 ml and 20 ml of ethanol, respectively, and dried under high vacuum at room temperature overnight.
- the first fraction (0.3 g) was shown by HPLC-UV/Vis-MS to be a mixture of anhydrolutein, alpha-cryptoxanthin, and beta-cryptoxanthin and the second fraction (1.2 g) was shown to be pure all-E-lutein (97%) but contained approximately 4% zeaxanthin.
- LCM berries (455.5 g) were rehydrated in a beaker containing 1000 ml of water overnight at room temperature. The water was decanted off and the LCM berries were vigorously homogenized with THF (2000 ml) and 10% ethanolic KOH (250 ml) at room temperature. The pH of the solution was maintained at 12 by monitoring the extraction and hydrolysis with an automatic pH-meter. During the course of the extraction an additional amount of 250 ml of 10% ethanolic KOH was needed to keep the pH at 12.
- the zeaxanthin crystals (0.48 g, 75% pure) were dissolved in THF (5 ml) and water (about 10 ml) was added to commence recrystallization. The mixture was stirred at room temperature for about 10 minutes and the solids were separated by centrifugation. After removal of the solution, the zeaxanthin crystals were washed with ethanol (about 5 ml), centrifuged, and dried under high vacuum for about 8 hours at room temperature. This gave 0.35 g of zeaxanthin which was shown by HPLC-UV/Visible photodiode array detection coupled with Mass Spectrometry (MS) to be 97% pure but contained about 3.5% of Z-zeaxanthins (Khachik et al. J. Chrom. Biomed. Appl. 582: 153-166, 1992).
- MS Mass Spectrometry
- the THF/water solution from the above recrystallization was evaporated to remove the THF and to precipitate small amount of zeaxanthin along with other carotenoids (0.1 g) which were separated by centrifugation.
- the mixture of carotenoids were washed with small amount of ethanol (1 ml) and dried under high vacuum. HPLC analysis of the dried solid showed that in addition to zeaxanthin, this fraction was enriched in alpha-cryptoxanthin, beta-cryptoxanthin, and beta- carotene.
- TLC Thin Layer Chromatography
- HPLC High Performance Liquid Chromatography
- chlorophylls were completely hydrolyzed to their water soluble derivatives.
- the mixture was filtered off and the solids were washed with THF (1000 ml).
- the solvents were evaporated under reduced pressure at approximately 40°C to almost dryness and the solids were stirred at room temperature with a 1/1 mixture of water and food grade ethanol (100 ml) for 10 minutes.
- the present invention has accomplished the isolation of lutein and zeaxanthin as well as a mixture of several rare carotenoids from plants in substantially pure form under controlled and mild condition to preserve the integrity of these essential dietary compounds.
- This economically viable process employs solvents which are not toxic and as a result, the carotenoids purified by this procedure can be safely used as nutritional supplements or food coloring additives.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/529,815 US6262284B1 (en) | 1998-10-21 | 1998-10-21 | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants |
AU12719/99A AU1271999A (en) | 1997-10-21 | 1998-10-21 | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6257297P | 1997-10-21 | 1997-10-21 | |
US60/062,572 | 1997-10-21 | ||
US7836098P | 1998-03-18 | 1998-03-18 | |
US60/078,360 | 1998-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999020587A1 true WO1999020587A1 (fr) | 1999-04-29 |
WO1999020587A8 WO1999020587A8 (fr) | 1999-08-26 |
Family
ID=26742423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/022229 WO1999020587A1 (fr) | 1997-10-21 | 1998-10-21 | Procede d'extraction et de purification de la luteine, de la zeaxanthine et de carotenoides rares dans les fleurs et plantes de tagete |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1271999A (fr) |
WO (1) | WO1999020587A1 (fr) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191293B1 (en) | 1998-04-20 | 2001-02-20 | Inexa, Industria Extractora C.A. | Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
WO2001055100A1 (fr) * | 2000-01-27 | 2001-08-02 | Dsm N.V. | Isolation de cristaux de carotenoide |
US6329557B1 (en) | 2000-06-09 | 2001-12-11 | Prodemex, S.A. De C.V. | Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
WO2002004415A3 (fr) * | 2000-07-12 | 2002-05-10 | Univ Maryland | Procede de purification et de cristallisation de carotenoides d'huile palmitique |
WO2002060864A1 (fr) * | 2001-01-30 | 2002-08-08 | Sabinsa Corporation | Procede permettant d'obtenir des compositions de luteine stable et des derives de luteine |
EP1361281A1 (fr) * | 2001-01-26 | 2003-11-12 | Fuji Chemical Industry Co., Ltd. | Procede de purification de xanthophylles brutes |
EP1371641A1 (fr) * | 2002-06-10 | 2003-12-17 | Adisseo France S.A.S. | Procédé de préparation et isolement de cristaux caroténoides |
WO2004018417A1 (fr) * | 2002-08-26 | 2004-03-04 | Kancor Flavours And Extracts Ltd | Procede ameliore pour la preparation de cristaux de xanthophylle |
EP1408737A2 (fr) * | 2001-06-29 | 2004-04-21 | Ball Horticultural Company | Oeillets d'inde tagetes erecta renfermant des compositions a base de carotenoides et des teneurs en carotenoides modifiees |
US6737535B2 (en) | 2002-06-05 | 2004-05-18 | Kancor Flavours And Extracts Limited | Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation |
US6818798B1 (en) | 2000-05-03 | 2004-11-16 | University Of Maryland, College Park | Process for making a (3R,3′R)-zeaxanthin precursor |
EP1531665A2 (fr) * | 2002-06-26 | 2005-05-25 | Ball Horticultural Company | Soucis tagetes erecta a compositions carotenoides et teneurs en carotenoides modifiees |
US6911564B2 (en) | 2000-07-27 | 2005-06-28 | University Of Maryland, College Park | Method for production of rare carotenoids from commercially available lutein |
US7115786B2 (en) | 2002-02-06 | 2006-10-03 | University Of Maryland, College Park | Method for production of β-cryptoxanthin and α-cryptoxanthin from commercially available lutein |
US7173145B2 (en) | 2001-11-29 | 2007-02-06 | University Of Maryland, College Park | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants |
WO2007087815A2 (fr) | 2004-12-17 | 2007-08-09 | Metanomics Gmbh | Procédé de contrôle de production de produits chimiques fins |
EP1857441A1 (fr) * | 2006-05-17 | 2007-11-21 | ZheJiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | Procédé de séparation et de purification d'esters d'acide gras de xanthophyll provenant d'oléorésine de soucis |
US7351424B2 (en) | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
CN101402597A (zh) * | 2008-10-31 | 2009-04-08 | 南京泛成生物化工有限公司 | 叶黄素提取工艺 |
CN102174005A (zh) * | 2011-01-25 | 2011-09-07 | 石河子大学医学院第一附属医院 | 一种从万寿菊干花中提取叶黄素的方法 |
JP4848420B2 (ja) * | 2005-04-25 | 2011-12-28 | カトラ フィトケム(インディア) プライヴェイト リミテッド | マリーゴールド由来カロテノイドの単離及び精製 |
CN102558008A (zh) * | 2011-09-08 | 2012-07-11 | 黑龙江省嘉宝生物技术开发有限公司 | 一种叶黄素的制备方法 |
CN103091446A (zh) * | 2013-01-31 | 2013-05-08 | 甘肃省农垦农业研究院 | 叶黄素酯皂化程度快速测定方法 |
CN103275088A (zh) * | 2013-05-30 | 2013-09-04 | 湖南炎帝生物工程有限公司 | 从念珠藻中分离叶绿素a与类胡萝卜素的方法 |
CN103992256A (zh) * | 2014-05-17 | 2014-08-20 | 昆明涞章医药科技有限公司 | 一种从金盏菊中制备高纯度叶黄素酯的方法 |
TWI466709B (zh) * | 2011-07-20 | 2015-01-01 | Nat Univ Chung Hsing | From the original berry Wolfberry a liquid - liquid freezing method for separation of high purity theaflavins palmitate Maize |
CN104447467A (zh) * | 2014-10-30 | 2015-03-25 | 蒋小春 | 一种提取枸杞中类胡萝卜素的方法 |
WO2015109657A1 (fr) * | 2014-01-27 | 2015-07-30 | 中国科学院大连化学物理研究所 | Procédé de fabrication de zéaxanthine naturelle au moyen d'une concentration in situ |
CN105017116A (zh) * | 2015-07-31 | 2015-11-04 | 江西恩泉油脂有限公司 | 一种叶黄素浸膏的皂化工艺 |
CN105503681A (zh) * | 2014-09-25 | 2016-04-20 | 赵军 | 高纯度枸杞玉米黄质棕榈酸酯的制备方法 |
CN107082756A (zh) * | 2017-03-17 | 2017-08-22 | 晨光生物科技集团股份有限公司 | 一种叶黄素晶体瞬时高效的工业制备方法 |
CN110563625A (zh) * | 2019-09-29 | 2019-12-13 | 山东天音生物科技有限公司 | 一种由万寿菊油树脂分离纯化玉米黄质的方法 |
CN110835315A (zh) * | 2019-10-28 | 2020-02-25 | 百瑞源枸杞股份有限公司 | 一种枸杞红素的制备方法 |
KR102161387B1 (ko) * | 2019-12-09 | 2020-09-29 | 대한켐텍 주식회사 | 루테인 포함 피부건강용 조성물 및 이를 포함하는 피부건강기능식품 |
WO2021019275A1 (fr) * | 2019-07-26 | 2021-02-04 | Universita' Degli Studi Di Cagliari | Isolement de caroténoïdes chromoplastidials à partir de fruits |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048203A (en) * | 1976-12-06 | 1977-09-13 | Thomas Philip | Purification of lutein-fatty acid esters from plant materials |
US5382714A (en) * | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
US5648564A (en) * | 1995-12-21 | 1997-07-15 | Kemin Industries, Inc. | Process for the formation, isolation and purification of comestible xanthophyll crystals from plants |
-
1998
- 1998-10-21 WO PCT/US1998/022229 patent/WO1999020587A1/fr active Application Filing
- 1998-10-21 AU AU12719/99A patent/AU1271999A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048203A (en) * | 1976-12-06 | 1977-09-13 | Thomas Philip | Purification of lutein-fatty acid esters from plant materials |
US5382714A (en) * | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
US5648564A (en) * | 1995-12-21 | 1997-07-15 | Kemin Industries, Inc. | Process for the formation, isolation and purification of comestible xanthophyll crystals from plants |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6191293B1 (en) | 1998-04-20 | 2001-02-20 | Inexa, Industria Extractora C.A. | Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
WO2001055100A1 (fr) * | 2000-01-27 | 2001-08-02 | Dsm N.V. | Isolation de cristaux de carotenoide |
US7015014B2 (en) | 2000-01-27 | 2006-03-21 | Dsm Ip Assets B.V. | Isolation of carotenoid crystals |
US6818798B1 (en) | 2000-05-03 | 2004-11-16 | University Of Maryland, College Park | Process for making a (3R,3′R)-zeaxanthin precursor |
US6329557B1 (en) | 2000-06-09 | 2001-12-11 | Prodemex, S.A. De C.V. | Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls |
WO2002004415A3 (fr) * | 2000-07-12 | 2002-05-10 | Univ Maryland | Procede de purification et de cristallisation de carotenoides d'huile palmitique |
US7119238B2 (en) | 2000-07-12 | 2006-10-10 | University Of Maryland | Process for purification and crystallization of palm oil carotenoids |
US6911564B2 (en) | 2000-07-27 | 2005-06-28 | University Of Maryland, College Park | Method for production of rare carotenoids from commercially available lutein |
EP1361281A1 (fr) * | 2001-01-26 | 2003-11-12 | Fuji Chemical Industry Co., Ltd. | Procede de purification de xanthophylles brutes |
EP1361281A4 (fr) * | 2001-01-26 | 2004-02-04 | Fuji Chem Ind Co Ltd | Procede de purification de xanthophylles brutes |
WO2002060864A1 (fr) * | 2001-01-30 | 2002-08-08 | Sabinsa Corporation | Procede permettant d'obtenir des compositions de luteine stable et des derives de luteine |
EP1408737A2 (fr) * | 2001-06-29 | 2004-04-21 | Ball Horticultural Company | Oeillets d'inde tagetes erecta renfermant des compositions a base de carotenoides et des teneurs en carotenoides modifiees |
EP1408737A4 (fr) * | 2001-06-29 | 2004-12-22 | Ball Horticultural Co | Oeillets d'inde tagetes erecta renfermant des compositions a base de carotenoides et des teneurs en carotenoides modifiees |
US7173145B2 (en) | 2001-11-29 | 2007-02-06 | University Of Maryland, College Park | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants |
US7115786B2 (en) | 2002-02-06 | 2006-10-03 | University Of Maryland, College Park | Method for production of β-cryptoxanthin and α-cryptoxanthin from commercially available lutein |
US6737535B2 (en) | 2002-06-05 | 2004-05-18 | Kancor Flavours And Extracts Limited | Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation |
WO2003104190A1 (fr) * | 2002-06-10 | 2003-12-18 | Adisseo France S.A.S. | Procede de formation et d'isolation de carotenoides cristallises |
EP1371641A1 (fr) * | 2002-06-10 | 2003-12-17 | Adisseo France S.A.S. | Procédé de préparation et isolement de cristaux caroténoides |
AU2003232424B2 (en) * | 2002-06-26 | 2008-04-24 | Ball Horticultural Company | Tagetes erecta marigolds with altered carotenoid compositions and ratios |
EP1531665A2 (fr) * | 2002-06-26 | 2005-05-25 | Ball Horticultural Company | Soucis tagetes erecta a compositions carotenoides et teneurs en carotenoides modifiees |
EP1531665A4 (fr) * | 2002-06-26 | 2006-03-22 | Ball Horticultural Co | Soucis tagetes erecta a compositions carotenoides et teneurs en carotenoides modifiees |
AU2002347590B2 (en) * | 2002-08-26 | 2008-01-03 | Omniactive Health Technologies Limited | An improved process for the preparation of xanthophyll crystals |
US6743953B2 (en) | 2002-08-26 | 2004-06-01 | Kancor Flavours & Extracts Ltd. | Process for the preparation of xanthophyll crystals |
AU2002347590B8 (en) * | 2002-08-26 | 2004-03-11 | Omniactive Health Technologies Limited | An improved process for the preparation of xanthophyll crystals |
WO2004018417A1 (fr) * | 2002-08-26 | 2004-03-04 | Kancor Flavours And Extracts Ltd | Procede ameliore pour la preparation de cristaux de xanthophylle |
EP2292598A3 (fr) * | 2002-08-26 | 2012-04-25 | Omniactive Health Technologies Limited | Procédé amélioré pour la préparation de crystaux de xanthophyll |
US7351424B2 (en) | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
WO2007087815A2 (fr) | 2004-12-17 | 2007-08-09 | Metanomics Gmbh | Procédé de contrôle de production de produits chimiques fins |
JP4848420B2 (ja) * | 2005-04-25 | 2011-12-28 | カトラ フィトケム(インディア) プライヴェイト リミテッド | マリーゴールド由来カロテノイドの単離及び精製 |
EP1857441A1 (fr) * | 2006-05-17 | 2007-11-21 | ZheJiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory | Procédé de séparation et de purification d'esters d'acide gras de xanthophyll provenant d'oléorésine de soucis |
CN101402597A (zh) * | 2008-10-31 | 2009-04-08 | 南京泛成生物化工有限公司 | 叶黄素提取工艺 |
CN102174005A (zh) * | 2011-01-25 | 2011-09-07 | 石河子大学医学院第一附属医院 | 一种从万寿菊干花中提取叶黄素的方法 |
TWI466709B (zh) * | 2011-07-20 | 2015-01-01 | Nat Univ Chung Hsing | From the original berry Wolfberry a liquid - liquid freezing method for separation of high purity theaflavins palmitate Maize |
CN102558008A (zh) * | 2011-09-08 | 2012-07-11 | 黑龙江省嘉宝生物技术开发有限公司 | 一种叶黄素的制备方法 |
CN103091446A (zh) * | 2013-01-31 | 2013-05-08 | 甘肃省农垦农业研究院 | 叶黄素酯皂化程度快速测定方法 |
CN103091446B (zh) * | 2013-01-31 | 2015-12-23 | 甘肃省农垦农业研究院 | 叶黄素酯皂化程度快速测定方法 |
CN103275088A (zh) * | 2013-05-30 | 2013-09-04 | 湖南炎帝生物工程有限公司 | 从念珠藻中分离叶绿素a与类胡萝卜素的方法 |
WO2015109657A1 (fr) * | 2014-01-27 | 2015-07-30 | 中国科学院大连化学物理研究所 | Procédé de fabrication de zéaxanthine naturelle au moyen d'une concentration in situ |
CN103992256A (zh) * | 2014-05-17 | 2014-08-20 | 昆明涞章医药科技有限公司 | 一种从金盏菊中制备高纯度叶黄素酯的方法 |
CN103992256B (zh) * | 2014-05-17 | 2016-09-07 | 昆明涞章医药科技有限公司 | 一种从金盏菊中制备高纯度叶黄素酯的方法 |
CN105503681A (zh) * | 2014-09-25 | 2016-04-20 | 赵军 | 高纯度枸杞玉米黄质棕榈酸酯的制备方法 |
CN104447467A (zh) * | 2014-10-30 | 2015-03-25 | 蒋小春 | 一种提取枸杞中类胡萝卜素的方法 |
CN105017116A (zh) * | 2015-07-31 | 2015-11-04 | 江西恩泉油脂有限公司 | 一种叶黄素浸膏的皂化工艺 |
CN107082756A (zh) * | 2017-03-17 | 2017-08-22 | 晨光生物科技集团股份有限公司 | 一种叶黄素晶体瞬时高效的工业制备方法 |
CN107082756B (zh) * | 2017-03-17 | 2018-11-23 | 晨光生物科技集团股份有限公司 | 一种叶黄素晶体的工业制备方法 |
WO2021019275A1 (fr) * | 2019-07-26 | 2021-02-04 | Universita' Degli Studi Di Cagliari | Isolement de caroténoïdes chromoplastidials à partir de fruits |
CN114401775A (zh) * | 2019-07-26 | 2022-04-26 | 卡利亚里大学 | 从果实中分离有色体类胡萝卜素 |
CN114401775B (zh) * | 2019-07-26 | 2023-11-07 | 卡利亚里大学 | 从果实中分离有色体类胡萝卜素 |
US12162827B2 (en) | 2019-07-26 | 2024-12-10 | Universita' Degli Studi Di Cagliari | Isolation of chromoplastid carotenoids from fruits |
CN110563625A (zh) * | 2019-09-29 | 2019-12-13 | 山东天音生物科技有限公司 | 一种由万寿菊油树脂分离纯化玉米黄质的方法 |
CN110835315A (zh) * | 2019-10-28 | 2020-02-25 | 百瑞源枸杞股份有限公司 | 一种枸杞红素的制备方法 |
KR102161387B1 (ko) * | 2019-12-09 | 2020-09-29 | 대한켐텍 주식회사 | 루테인 포함 피부건강용 조성물 및 이를 포함하는 피부건강기능식품 |
Also Published As
Publication number | Publication date |
---|---|
AU1271999A (en) | 1999-05-10 |
WO1999020587A8 (fr) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6262284B1 (en) | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants | |
WO1999020587A1 (fr) | Procede d'extraction et de purification de la luteine, de la zeaxanthine et de carotenoides rares dans les fleurs et plantes de tagete | |
US7173145B2 (en) | Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants | |
CA2496495C (fr) | Procede ameliore pour la preparation de cristaux de xanthophylle | |
KR100214430B1 (ko) | 비누화된 금잔화 함유수지로부터 얻는 루테인의 분리, 정제 및 재결정방법 | |
US7271298B2 (en) | Process for isolation and purification of xanthophyll crystals from plant oleoresin | |
US6380442B1 (en) | Process for the isolation of mixed carotenoids from plants | |
EP2473065B1 (fr) | Composition de xanthophiles comprenant des pigments de la macula et procede de preparation | |
EP1963245B1 (fr) | Procede de purification de xanthophylles libres | |
EP1704134B1 (fr) | Procede d'isolation, de purification et de formulation d'une pate de luteine stable, de qualite commerciale a partir d'oleoresine | |
US8212063B2 (en) | Xanthophyll composition containing trans, meso-zeaxanthin, trans, R, R-zeaxanthin and trans, R, R-lutein useful for nutrition and health care and a process for its preparation | |
US20120107380A1 (en) | Methods of saponifying xanthophyll esters and isolating xanthophylls | |
WO2003104191A1 (fr) | Nouveau concentre d'esters de xanthophylle enrichi en trans-luteine et procede servant a la preparation de ce concentre | |
WO2002060865A1 (fr) | Procede d'obtention de zeaxanthine, de cryptoxanthine & d'autres carotenoides de grande purete a partir de piments byadagi/chappatta et composition carotenoide | |
US11654173B2 (en) | Purified xanthophyll composition comprising (trans,R,R)-lutein and(trans,R,R)-zeaxanthin and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page |
Free format text: REVISED ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09529815 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/A/2000/004012 Country of ref document: MX |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |